Please provide your email address to receive an email when new articles are posted on . PrEP adherence and engagement continues to be an issue for young men who have sex with men. PrEP use among this ...
The U.S. Food and Drug Administration approved a generic version of Truvada, the only drug approved so far to use as pre-exposure prophylaxis, a prevention method known as PrEP, which when taken daily ...
The U.S. Food and Drug Administration has approved the first generic version of Truvada, a combination pill used for both HIV treatment and prevention, but it will not soon hit pharmacy shelves, ...
The US Food and Drug Administration (FDA) has approved a generic form of the drug Truvada, an antiretroviral and pre-exposure prophylaxis (PrEP) from Gilead Sciences. The approval notice was posted on ...
Generic PrEP use could reduce new HIV acquisitions, save lives among young men who have sex with men
Anne Neilan, MD, a physician-scientist in the division of Infectious Diseases at Massachusetts General Hospital is the senior author of a recently published paper in Clinical Infectious Diseases, ...
With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
HHS has announced that Gilead will donate its pre-exposure prophylaxis (PrEP) pill Truvada for up to 200,000 people in a multiyear agreement, just a day after the pharma giant announced that a generic ...
Gilead Sciences announced Wednesday that a generic version of Truvada will be available in September 2020, one year earlier than expected. Truvada is the pill used for HIV pre-exposure prophylaxis, or ...
Gilead Sciences is relaxing its patent on Truvada, the brand name for their pre-exposure prophylaxis (PrEP) medication, allowing Teva Pharmaceuticals to release a generic version in 2020. The news ...
Generic drugmaker Lupin Inc’s instructions for using its proposed colonoscopy-prep solution do not induce patients or physicians to infringe Ferring Pharmaceuticals' patent on administering name-brand ...
A U.K. court ruled against a patent extension filed by Gilead Sciences, the manufacturer of the highly effective HIV prevention drug Truvada, which will open the U.K. market to a generic version of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback